Sil: A Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Li, Mo Fei ^a,b   Zhang, Bao Cun ^a,b   Li, Jun ^a,c   Sun, Li ^a,d  

^a INSTITUTE OF OCEANOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c LAKE SUPERIOR STATE UNIVERSITY   (United States)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; RECOMBINANT PROTEIN; SIL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DISEASE ACTIVITY; DNA SEQUENCE; GROWTH INHIBITION; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOMODULATION; INNATE IMMUNITY; LACTOCOCCUS LACTIS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION; SCOPHTHALMUS MAXIMUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS INIAE;

ANIMALS; BACTERIOCINS; CELLS, CULTURED; FISH DISEASES; FLATFISHES; IMMUNITY, INNATE; MONOCYTES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; VIRULENCE FACTORS;

EID: 84899766972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096222     Document Type: Article

References (63)

1. Agnew W, Barnes AC (2007) Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol 122: 1-15. (Pubitemid 46589915)
2. Du J (2001) Streptococcus diseases of farmed marine fish. Mod Fish 5: 28-29.
3. Baiano JC, Barnes AC (2009) Towards control of Streptococcus iniae. Emerg Infect Dis 15: 1891-1896.
4. Low DE, Liu E FJ, McGeer A (1999) Streptococcus iniae: an emerging pathogen in the aquaculture industry. Emerging infections 3. Washington DC: ASM Press. pp. 53-66.
5. Allen JP, Neely MN (2012) CpsY influences Streptococcus iniae cell wall adaptations important for neutrophil intracellular survival. Infect Immun 80: 1707-1715.
6. Baiano JC, Tumbol RA, Umapathy A, Barnes AC (2008) Identification and molecular characterisation of a fibrinogen binding protein from Streptococcus iniae. BMC Microbiol 8: 67.
7. Buchanan JT, Stannard JA, Lauth X, Ostland VE, Powell HC, et al. (2005) Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Infect Immun 73: 6935-6944. (Pubitemid 41368862)
8. Fuller JD, Camus AC, Duncan CL, Nizet V, Bast DJ, et al. (2002) Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun 70: 5730-5739.
9. Locke JB, Aziz RK, Vicknair MR, Nizet V, Buchanan JT (2008) Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development. PLoS One 3: 2824.
10. Eyngor M, Lublin A, Shapira R, Hurvitz A, Zlotkin A, et al. (2010) A pivotal role for the Streptococcus iniae extracellular polysaccharide in triggering proinflammatory cytokines transcription and inducing death in rainbow trout. FEMS Microbiol Lett 305: 109-120.
11. Milani CJ, Aziz RK, Locke JB, Dahesh S, Nizet V, et al. (2010) The novel polysaccharide deacetylase homologue Pdi contributes to virulence of the aquatic pathogen Streptococcus iniae. Microbiology 156: 543-554.
12. Locke JB, Colvin KM, Datta AK, Patel SK, Naidu NN, et al. (2007) Streptococcus iniae capsule impairs phagocytic clearance and contributes to virulence in fish. J Bacteriol 189: 1279-1287. (Pubitemid 46239749)
13. Lowe BA, Miller JD, Neely MN (2007) Analysis of the polysaccharide capsule of the systemic pathogen Streptococcus iniae and its implications in virulence. Infect Immun 75: 1255-1264. (Pubitemid 46385817)
14. Miller JD, Neely MN (2005) Large-scale screen highlights the importance of capsule for virulence in the zoonotic pathogen Streptococcus iniae. Infect Immun 73: 921-934. (Pubitemid 40165751)
15. Zinkernagel AS, Timmer AM, Pence MA, Locke JB, Buchanan JT, et al. (2008) The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe 14: 170-178.
16. Heng NC, Tagg JR (2006) What's in a name? Class distinction for bacteriocins. Nat Rev Microbiol 4: 117-129.
17. Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788. (Pubitemid 41518738)
18. Lee H, Kim HY (2011) Lantibiotics, class I bacteriocins from the genus Bacillus. J Microbiol Biotechnol 21: 229-235.
19. Nagao J, Asaduzzaman SM, Aso Y, Okuda K, Nakayama J, et al. (2006) Lantibiotics: insight and foresight for new paradigm. J Biosci Bioeng 102: 139-149. (Pubitemid 44559759)
20. Nishie M, Nagao J, Sonomoto K (2012) Antibacterial peptides "bacteriocins": an overview of their diverse characteristics and applications. Biocontrol Sci 17: 1-16.
21. Bierbaum G, Sahl HG (2009) Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10: 2-18.
22. Martin NI, Breukink E (2007) Expanding role of lipid II as a target for lantibiotics. Future Microbiol 2: 513-525. (Pubitemid 47578215)
23. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G et al. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276:1772-1779. (Pubitemid 32109649)
24. Cotter PD, Ross RP, Hill C (2013) Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 11: 95-105.
25. Heng NCK, Wescombe PA, Burton JP, Jack RW, Tagg JR (2007) The diversity of bacteriocins in Gram-positive Bacteria. In: Riley MAY, Chavan MA, editors. Bacteriocins Ecology and Evolution. Heidelberg. pp. 5-18.
26. Sandiford S, Upton M (2012) Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against staphylococci. Antimicrob Agents Chemother 56: 1539-1547.
27. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR (2006) A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 100: 754-764.
28. Tagg JR (2004) Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Indian J Med Res 119: 13-16.
29. Zhang B, Zhang J, Sun L (2014) Streptococcus iniae SF1: complete genome sequence, proteomic profile, and immunoprotective antigens. Plos ONE 9:e91324.
30. Martínez B, Fernández M, Suárez JE, Rodríguez A (1999) Synthesis of lactococcin 972, a bacteriocin produced by Lactococcus lactis IPLA 972, depends on the expression of a plasmid-encoded bicistronic operon. Microbiology 145: 3155-3161.
31. Wang HR, Hu YH, Zhang WW, Sun L (2009) Construction of an attenuated Pseudomonas fluorescens strain and evaluation of its potential as a cross-protective vaccine. Vaccine 27: 4047-4055.
32. Cheng S, Hu YH, Jiao XD, Sun L (2010) Identification and immunoprotective analysis of a Streptococcus iniae subunit vaccine candidate. Vaccine 28: 2636-2641.
33. Zhang M, Sun K, Sun L (2008) Regulation of autoinducer 2 production and luxS expression in a pathogenic Edwardsiella tarda strain. Microbiol SGM 154: 206-209.
34. Zheng WJ, Hu YH, Xiao ZZ, Sun L (2010) Cloning and analysis of a ferritin subunit from turbot (Scophthalmus maximus). Fish Shellfish Immunol 28: 829-836.
35. Wang H, Hu Y, Zhang W, Sun L (2009) Construction of an attenuated Pseudomonas fluorescens strain and evaluation of its potential as a cross-protective vaccine. Vaccine 27:4047-4055.
36. Sun K, Zhang W, Hou J, Sun L (2009) Immunoprotective analysis of VhhP2, a Vibrio harveyi vaccine candidate. Vaccine. 27:2733-2740.
37. Hu YH, Zheng WJ, Sun L (2010) Identification and molecular analysis of a ferritin subunit from red drum (Sciaenops ocellatus). Fish Shellfish Immunol 28: 678-686.
38. Sun Y, Liu C, Sun L (2011) Comparative study of the immune effect of an Edwardsiella tarda antigen in two forms: subunit vaccine vs DNA vaccine. Vaccine 29:2051-2057.
39. Hou J, Zhang W, Sun L (2009) Immunoprotective analysis of two Edwardsiella tarda antigens. J Gen Appl Microbiol 55:57-61.
40. Chen C, Hu Y, Xiao Z, Sun L (2013) SmCCL19, a CC chemokine of turbot Scophthalmus maximus, induces leukocyte trafficking and promotes anti-viral and anti-bacterial defense. Fish Shellfish Immunol 35: 1677-1682.
41. Jiao XD, Zhang M, Hu YH, Sun L (2009) Construction and evaluation of DNA vaccines encoding Edwardsiella tarda antigens. Vaccine 27: 5195-5202.
42. Sun Y, Zheng WJ, Hu YH, Sun BG, Sun L (2012) Edwardsiella tarda Eta1, an in vivo induced antigen that is involved in host infection. Infect Immun 80: 2948-2955.
43. Chung S, Secombes CJ (1988) Analysis of events occurring within teleost macrophages during the respiratory burst. Comp Biochem Physiol 89: 539-544.
44. Phelan RW, Barret M, Cotter PD, O'Connor PM, Chen R, et al. (2013) Subtilomycin: a new lantibiotic from Bacillus subtilis strain MMA7 isolated from the marine sponge Haliclona simulans. Mar Drugs 11: 1878-1898.
45. Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF (2007) Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci USA 104: 2384-2389. (Pubitemid 46391406)
46. Muriana PM, Klaenhammer TR (1991) Purification and partial characterization of lactacin F, a bacteriocin produced by Lactobacillus acidophilus 11088. Appl Environ Microbiol 57: 114-121.
47. Ghadbane M, Harzallah D, Jaouadi B, Ibn LA, Belhadj H (2013) New Bacteriocin from Bacillus clausii StrainGM17: Purification, Characterization, and Biological Activity. Appl Biochem Biotechnol 171: 2186-2200.
48. Pasteris SE, Vera Pingitore E, Ale CE, Nader-Macías ME (2013) Characterization of a bacteriocin produced by Lactococcus lactis subsp. Lactis CRL 1584 isolated from a Lithobates catesbeianus hatchery. World J Microbiol Biotechnol.
49. Zhang H, Liu L, Hao Y, Zhong S, Liu H, et al. (2013) Isolation and partial characterization of a bacteriocin produced by Lactobacillus plantarum BM-1 isolated from a traditionally fermented Chinese meat product. Microbiol Immunol 57: 746-755.
50. Martinez B, Juan ES, Ana R (1996) Lactococcin 972: a hornodimeric lactococcal bacteriocin whose primary target is not the plasma membrane. Microbiology 142: 2393-2398. (Pubitemid 26333770)
51. Saddam SA, Anas AA, Tareq MO, Salam I, Richard H (2013) Inhibition of Cronobacter sakazakii by Heat Labile Bacteriocins Produced by Probiotic LAB Isolated from Healthy Infants. J Food Sci 78: 1416-1420.
52. Swe PM, Cook GM, Tagg JR, Jack RW (2009) Mode of action of dysgalacticin: a large Heat-labile Bacteriocins. J Antimicrob Chemother 63: 679-686.
53. Kjos M, Nes IF, Diep DB (2009) Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells. Microbiology 155: 2949-2961.
54. Martínez B, Rodríguez A, Suárez JE (2000) Lactococcin 972, a bacteriocin that inhibits septum formation in lactococci. Microbiology 146:949-955.
55. Martínez B, Zomer AL, Rodríguez A, Kok J, Kuipers OP (2007) Cell envelope stress induced by the bacteriocin Lcn972 is sensed by the lactococcal two-component system CesSR. Mol Microbiol 64: 473-486. (Pubitemid 46632627)
56. Martínez B, Böttiger T, Schneider T, Rodríguez A, Sahl HG, et al. (2008) Specific interaction of the unmodified bacteriocin Lactococcin 972 with the cell wall precursor lipid II. Appl Environ Microbiol. 74: 4666-4670.
57. Hammami R, Fernandez B, Lacroix C, Fliss I (2013) Anti-infective properties of bacteriocins: an update. Cell Mol Life Sci 70: 2947-2967.
58. Lopez FE, Vincent PA, Zenoff AM, Salomon RA, Farias RN (2007) Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection. J Antimicrob Chemother 59: 676-680. (Pubitemid 47073401)
59. Rihakova J, Cappelier JM, Hue I, Demnerova K, Fédérighi M, et al. (2010) In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes. Antimicrob Agents Chemother 54: 563-564.
60. Salvucci E, Saavedra L, Hebert EM, Haro C, Sesma F (2012) Enterocin CRL35 inhibits Listeria monocytogenes in a murine model. Foodborne Pathog Dis 9: 68-74.
61. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, et al. (2008) The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 76: 4163-4175.
62. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, et al. (2010) Oral bacteria as potential probiotic for the pharyngeal mucosa. Appl Environ Microbiol 76: 3948-3958.
63. Jeremy PB, Philip AW, Jean MM, Melissa HC, Kyle M, et al. (2013) Persistence of the Oral Probiotic Streptococcus salivarius M18 Is Dose Dependent and Megaplasmid Transfer Can Augment Their Bacteriocin Production and Adhesion Characteristics. Plos one 8: e65991.